144 results
Page 4 of 8
8-K
EX-10.1
qklav99oavfmd boey5
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
8-K/A
EX-10.2
m96f1m
29 Sep 20
Departure of Directors or Certain Officers
4:39pm
8-K
EX-10.2
rqcqog3n brmc4
29 Sep 20
Departure of Directors or Certain Officers
7:06am
DEFA14A
bx34aya
19 Aug 20
Additional proxy soliciting materials
6:13am
8-K
EX-99.2
zuhjlr0qhkbwf1jh
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
EX-99.1
uw8tgojapqmhrw fqs
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K/A
EX-99.2
phld7
26 Jun 20
Other Events
5:08pm
8-K
EX-99.1
5st79 ivv92dmdoqmyb
3 Jun 20
Regulation FD Disclosure
12:00am
8-K
EX-10.2
jk19puak sgxhk9hp2i
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.4
uipvdsux8 z1ylkbrfb
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.1
nr3dzs ui55mv
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
mxmod8ko
29 Apr 20
Proxy related to merger
3:20pm